Journal
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
Volume 34, Issue -, Pages -Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/2058738420941754
Keywords
chloroquine; favipiravir; hydroxychloroquine; lopinavir; ototoxicity; remdesivir; SARS-CoV-2 (Covid-19) pandemic
Categories
Ask authors/readers for more resources
Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesivir, favipiravir and lopinavir can all present potential ototoxic side effects. The data in the literature do not offer specific information on their potential synergetic effects nor on their interactions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available